4 Charts that Prove the Mental Illness Argument Against Gun Control is Bunk

Another week, another mass shooting in the United States. Barack Obama is furious at congress for its continual unwillingness to pass comprehensive gun control. Jeb Bush says “stuff happens”:

Once again the right is coming out with the same tired arguments, claiming that guns have nothing to do with gun violence, that mental illness is the culprit. This argument is facile and demonstrably wrong. I can show you why in four charts.

Continue reading “4 Charts that Prove the Mental Illness Argument Against Gun Control is Bunk”

Trump’s Tax Plan is Regressive and Unrealistic, Copies Bush and Romney

I was disappointed to read Donald Trump‘s tax plan today. In recent weeks, Trump has been talking a pretty progressive game on taxes. Many of us, myself included, speculated that Trump might be a bit left wing on this issue and might be attempting to shift the Republican Party a to the left on economic issues. Unfortunately, this appears to have been wishful thinking. Trump’s new plan is almost precisely the same as Jeb Bush‘s and Mitt Romney’s. This still puts him to the left of flat tax and fair tax candidates (Carson, Cruz, Paul, Huckabee, Perry, Walker all explicitly endorsed one or both, while Rubio and Kasich have expressed interest in ultimately going to a flat tax), but it puts him to the right of Hillary Clinton and far, far to the right of Bernie Sanders. So let’s talk a bit about how the Romney/Bush/Trump tax plan works, why it’s so disappointing, and what the differences are between the various versions of the plan.

Continue reading “Trump’s Tax Plan is Regressive and Unrealistic, Copies Bush and Romney”

Martin Shkreli is the Product of a Broken Healthcare System

A lot of people are very angry with Martin Shkreli. Shkreli is CEO of Turing Pharmaceuticals. Turing recently purchased the rights to Daraprim, a drug that treats toxoplasmosis, a condition that poses the greatest threat to people with weakened immune systems, such as AIDS patients. 4,400 people are hospitalized with the condition each year in the US, and about 327 people die on average each year. Once Turing acquired Daraprim, it promptly raised the price from $13.50 per pill to $750. Turing and Shkreli claimed that the price increase was necessary to make a profit and to pay for research and development into new toxoplasmosis drugs, but the medical establishment and the public strongly disagree. Dr. David Relman, chief of infectious diseases at VA Palo Alto Healthcare System, told Fortune:

We are not in dire need of new drugs for toxoplasmosis right now. There is no significant drug resistance problem with toxoplasmosis. We do not need them to be undertaking some self-serving marketing campaign. There is no public health need for such. This is simply about greed.

The HIV Medicine Association and the Infectious Diseases Society of America concurred, writing a joint letter condemning the move. But in going after Shkreli and Turing individually, we’re collectively missing the point–they are a symptom of a much larger prescription drug problem in America.

Continue reading “Martin Shkreli is the Product of a Broken Healthcare System”

Hillary Clinton Started the Whole “Obama is a Muslim” Thing

Over the last week, republican candidates Donald Trump and Ben Carson have been taking a lot of heat–Trump for refusing to deny that Obama is a Muslim foreigner, Carson for explicitly stating that Muslims should not be president. We’ll discuss what both of them said, but I want to remind everyone of something we seem to have forgotten–it was Hillary Clinton who started this, and any person who supports Clinton while criticizing Trump or Carson is at best deeply ignorant of Clinton’s past and at worst a naked hypocrite.

Continue reading “Hillary Clinton Started the Whole “Obama is a Muslim” Thing”

The Wall Street Journal is Telling Awful Lies about Bernie Sanders

Over the last few days, I’ve seen a deeply misleading claim circulating around the internet–that Bernie Sanders is supposedly going to increase government spending by $18 trillion over 10 years. This claim originates in a Wall Street Journal article by Laura Meckler. The article is so deeply misleading that Gerald Friedman, the economist cited by the WSJ, has felt compelled to come forward and explain that his research does not at all support the WSJ’s conclusion. Indeed, Friedman claims that Sanders’ plan will actually save money. To understand how, we need to know just a little bit about healthcare economics.

Continue reading “The Wall Street Journal is Telling Awful Lies about Bernie Sanders”